Cargando…
Visceral Leishmaniasis Treatment, Italy
First-line drug treatment was recorded in 573 immunocompetent patients with visceral leishmaniasis in Italy. In the past 12 years, the proportion of antimonial treatments decreased from 100% to 2.8%, while the proportion of amphotericin B treatments increased from 0% to 97.2%. The countrywide change...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Centers for Disease Control and Prevention
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034325/ https://www.ncbi.nlm.nih.gov/pubmed/14720406 http://dx.doi.org/10.3201/eid0912.030178 |